Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrainline Regulatory News (TRN)

Share Price Information for Trainline (TRN)

Share Price is delayed by 15 minutes
Get Live Data
210.60    0.00 (0.00%)
Bid:
211.60
Ask:
212.20
Spread: 0.60 (0.284%)
Market Cap: £740.27m
TRN Live PriceLast checked at - London Stock Exchange

Intraday Trainline Share Chart

Stabilisation Notice

21 Jun 2019 07:06

RNS Number : 0073D
Morgan Stanley & Co. Int'l plc
21 June 2019
Β 

NotΒ forΒ distribution,Β directly or indirectly, in orΒ intoΒ theΒ United StatesΒ orΒ anyΒ jurisdiction inΒ whichΒ such distributionΒ would beΒ unlawful.

Trainline plc

StabilisationΒ Notice

21/06/19

Morgan Stanley & Co. International plc (contact: James Manson-Bahr; telephone: +44 20 7425-3672) hereby gives notice, as Stabilisation Manager, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014.

Β 

The securities:

Issuer:

Trainline plc

Securities:

Ordinary shares ("Shares") of the Issuer (ISIN: GB00BKDTK925)

Offer size:

271,655,470 ("Offer Shares") (excluding the over-allotment option)

Offer price:

350 pence

Stabilisation:

Stabilising Manager(s):

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Stabilisation period expected to start on:

Friday 21st June 2019

Stabilisation period expected to end no later than:

Friday 19th July 2019

Maximum size of over-allotment facility:

Up to 40,748,321 shares

Stabilisation trading venue:

London Stock Exchange

Over-allotment Option:

Terms:

KKR Victoria Aggregator L.P. has granted Morgan Stanley & Co. International plc, in its capacity as stabilisation manager, and for the account of the underwriters, the option to acquire up to an additional 40,748,321 Shares at the Offer Price (representing up 15 per cent of the Offer size).

Duration:

This option may be executed at any time during the stabilisation period.

Β 

Β 

InΒ connectionΒ withΒ theΒ offerΒ ofΒ theΒ aboveΒ securities,Β the Stabilisation Manager(s)Β mayΒ over-allot theΒ securitiesΒ orΒ effectΒ transactionsΒ withΒ aΒ viewΒ to supportingΒ theΒ marketΒ priceΒ of the securities during the stabilisation period at aΒ levelΒ higher than thatΒ whichΒ mightΒ otherwiseΒ prevail.Β However,Β stabilisation may not necessarily occur andΒ any stabilisationΒ action,Β ifΒ begun, mayΒ ceaseΒ atΒ anyΒ time. AnyΒ stabilisationΒ actionΒ orΒ over-allotmentΒ shallΒ beΒ conductedΒ in accordanceΒ with allΒ applicableΒ lawsΒ and rules.

ThisΒ announcementΒ isΒ forΒ informationΒ purposesΒ onlyΒ andΒ doesΒ notΒ constituteΒ anΒ invitationΒ or offerΒ toΒ underwrite,Β subscribeΒ forΒ orΒ otherwiseΒ acquireΒ orΒ disposeΒ ofΒ anyΒ securitiesΒ ofΒ theΒ Issuer in anyΒ jurisdiction.

ThisΒ announcementΒ andΒ theΒ offerΒ ofΒ theΒ securitiesΒ toΒ whichΒ itΒ relatesΒ areΒ only addressedΒ toΒ and directedΒ atΒ personsΒ outside the United KingdomΒ andΒ personsΒ in the UnitedΒ KingdomΒ whoΒ have professionalΒ experienceΒ in mattersΒ related toΒ investmentsΒ orΒ whoΒ areΒ highΒ netΒ worthΒ persons withinΒ articleΒ 12(5)Β ofΒ theΒ FinancialΒ ServicesΒ andΒ MarketsΒ ActΒ 2000Β (FinancialΒ Promotion) OrderΒ 2005 and mustΒ notΒ beΒ acted onΒ orΒ reliedΒ on byΒ otherΒ personsΒ inΒ theΒ UnitedΒ Kingdom.

InΒ addition,Β ifΒ andΒ to theΒ extentΒ that thisΒ announcementΒ isΒ communicatedΒ in,Β orΒ theΒ offerΒ of the securitiesΒ toΒ whichΒ itΒ relatesΒ isΒ madeΒ in,Β anyΒ EEAΒ MemberΒ StateΒ thatΒ hasΒ implementedΒ Directive 2003/71/EC, as amendedΒ (togetherΒ withΒ anyΒ applicableΒ implementingΒ measuresΒ inΒ anyΒ MemberΒ State,Β the "Prospectus Directive")Β beforeΒ theΒ publicationΒ ofΒ aΒ prospectusΒ inΒ relation toΒ theΒ securitiesΒ which hasΒ beenΒ approvedΒ byΒ theΒ competentΒ authorityΒ inΒ thatΒ MemberΒ StateΒ inΒ accordanceΒ withΒ the ProspectusΒ DirectiveΒ (orΒ whichΒ hasΒ beenΒ approvedΒ byΒ aΒ competentΒ authority inΒ anotherΒ Member StateΒ andΒ notifiedΒ toΒ theΒ competentΒ authority inΒ thatΒ MemberΒ StateΒ inΒ accordanceΒ withΒ the ProspectusΒ Directive),Β thisΒ announcementΒ andΒ theΒ offerΒ areΒ onlyΒ addressedΒ toΒ andΒ directedΒ at personsΒ inΒ thatΒ MemberΒ StateΒ whoΒ areΒ qualifiedΒ investorsΒ withinΒ theΒ meaningΒ of theΒ Prospectus DirectiveΒ (orΒ whoΒ areΒ otherΒ personsΒ toΒ whomΒ theΒ offerΒ may lawfullyΒ beΒ addressed)Β andΒ mustΒ not beΒ acted on orΒ relied on byΒ otherΒ persons inΒ thatΒ MemberΒ State.

ThisΒ announcementΒ isΒ notΒ anΒ offerΒ ofΒ securitiesΒ forΒ saleΒ intoΒ theΒ UnitedΒ States.Β TheΒ securities haveΒ notΒ been,Β andΒ willΒ notΒ be,Β registeredΒ underΒ theΒ UnitedΒ StatesΒ SecuritiesΒ ActΒ ofΒ 1933Β and may notΒ beΒ offeredΒ orΒ soldΒ inΒ theΒ UnitedΒ StatesΒ absentΒ registrationΒ orΒ anΒ exemptionΒ from registration. ThereΒ willΒ beΒ no publicΒ offerΒ ofΒ securitiesΒ in theΒ United States.

END.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
STAFBMFTMBMTMJL
Date   Source Headline
29th Jun 20262:20 pmRNSTransaction in Own Shares
24th Jun 20265:15 pmRNSHolding(s) in Company
24th Jun 20267:00 amRNSDirectorate change
22nd Jun 20262:08 pmRNSTransaction in Own Shares
18th Jun 20263:31 pmRNSResult of AGM
16th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20262:17 pmRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 202612:57 pmRNSHolding(s) in Company
27th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:37 pmRNSDirectorate change
22nd May 202612:31 pmRNSAnnual Financial Report
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20262:09 pmRNSHolding(s) in Company
14th May 20265:35 pmRNSHolding(s) in Company
14th May 202611:00 amRNSDirector/PDMR Shareholding
13th May 20264:32 pmRNSHolding(s) in Company
13th May 20267:01 amRNSHolding(s) in Company
13th May 20267:00 amRNSTransaction in Own Shares
7th May 202612:15 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSResults for the twelve months ended 28 Feb 2026
5th May 20263:41 pmRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20263:45 pmRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20263:05 pmRNSTransaction in Own Shares
30th Mar 20261:28 pmRNSHolding(s) in Company
30th Mar 20267:30 amRNSDirector/PDMR Shareholding
25th Mar 20265:33 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 202612:13 pmRNSHolding(s) in Company
20th Mar 202612:23 pmRNSHolding(s) in Company
20th Mar 20267:00 amRNSHolding(s) in Company
18th Mar 20264:00 pmRNSHolding(s) in Company
17th Mar 202610:21 amRNSTransaction in Own Shares
16th Mar 20265:42 pmRNSHolding(s) in Company
16th Mar 20268:36 amRNSHolding(s) in Company
16th Mar 20268:36 amRNSHolding(s) in Company
13th Mar 202611:24 amRNSHolding(s) in Company
13th Mar 202611:24 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSTRADING STATEMENT AND NOTICE OF FULL YEAR RESULTS
11th Mar 20265:17 pmRNSHolding(s) in Company
11th Mar 20265:17 pmRNSHolding(s) in Company
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.